Jaime Bashore Long
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Jaime Bashore Long has a total of 52 co-authors. Here are the top co-authors by number of shared publications:
Dobie L. Giles
Obstetrics and Gynecology, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin (Dr. Giles)
4 shared publications- Javier F. Magrina
Department of Medical and Surgical Gynecology, Mayo Clinic, 5779 E. Mayo Blvd., 3(rd) Floor, Phoenix, 85054, Arizona, USA
3 shared publications Paul M. Magtibay
3 shared publicationsSarah S. Boyd
Department of Obstetrics and Gynecology, Penn State Health Milton S. Hershey Medical Center, Hershey, PA
3 shared publications- Sarah Samuel Boyd
Department of Obstetrics and Gynecology, Penn State Health Milton S. Hershey, Medical Center, Hershey, USA
3 shared publications - Allen R. Kunselman
Department of Public Health Sciences, Penn State College of Medicine, Hershey, PA, USA
2 shared publications
Latest Publications
- Open Access
- 24 September 2025
- Published by MDPI AG in Anesthesia Research
- Vol. 2 (4) , 21
Postoperative Pain and Opioid Use in Urogynecology Patients
Opioid use disorder remains a leading national cause of mortality. Physician opioid prescribing contributes to this crisis. In urogynecology, most of these prescriptions are aimed at addressing postoperative pain. This expert review examines the factors that contribute to postoperative pain and opioid use in urogynecologic patients. We discuss patient characteristics, physician interventions and alternative therapies that may influence postoperative pain and opioid use. By identifying patients at higher risk for postoperative pain and opioid use and utilizing evidence-based strategies to mitigate postoperative pain, physicians caring for urogynecology patients can both reduce postoperative opioid use while still providing adequate patient pain control.
- 24 September 2025
- Published by MDPI AG in Anesthesia Research
- Vol. 2 (4) , 21
Open AccessPostoperative Pain and Opioid Use in Urogynecology Patients
Opioid use disorder remains a leading national cause of mortality. Physician opioid prescribing contributes to this crisis. In urogynecology, most of these prescriptions are aimed at addressing postoperative pain. This expert review examines the factors that contribute to postoperative pain and opioid use in urogynecologic patients. We discuss patient characteristics, physician interventions and alternative therapies that may influence postoperative pain and opioid use. By identifying patients at higher risk for postoperative pain and opioid use and utilizing evidence-based strategies to mitigate postoperative pain, physicians caring for urogynecology patients can both reduce postoperative opioid use while still providing adequate patient pain control.
- Open Access
- 12 April 2023
- Published by Elsevier in Data in Brief
- Vol. 48, 109144
Liberal vs. restricted opioid prescribing following midurethral sling dataset
- 12 April 2023
- Published by Elsevier in Data in Brief
- Vol. 48, 109144
Open AccessLiberal vs. restricted opioid prescribing following midurethral sling dataset
- 9 May 2022
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 227 (2) , 313.e1-313.e9
A randomized trial of standard vs restricted opioid prescribing following midurethral sling
- 9 May 2022
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 227 (2) , 313.e1-313.e9
A randomized trial of standard vs restricted opioid prescribing following midurethral sling
- Open Access
- 15 November 2021
- Published by Springer Nature in Cureus
- Vol. 13 (11)
Opioid Prescribing and Utilization Following Isolated Mid-Urethral Sling
Introduction: Overprescribing by providers is a leading contributor to the opioid crisis. Despite available information regarding the role that physician prescribing plays in the community availability of opioids, guidelines for the management of acute pain remain sparse. This project aims to evaluate opioid prescribing, opioid usage patterns, and postoperative pain control in patients undergoing isolated mid-urethral sling (MUS) placement. Methods: Patients who underwent isolated MUS placement from March 19, 2019 through March 19, 2020 were contacted by telephone in May 2020 and asked a series of questions examining opioid usage, postoperative pain, what they did with unused opioids, and whether they had received education on disposal techniques. A chart review was utilized to determine the amount of opioid prescribed, the presence of any operative complications, and medical and demographic characteristics of subjects. Results: A total of 53 subjects met inclusion criteria, of which 31 participated in a phone interview. Of the 53 subjects, 54.7% received a postoperative opioid prescription, and all but two of these subjects filled their prescription. Of the interviewed subjects, only 66.6% who filled a prescription reported using opioids Fifty percent (n=6) of patients that required oxycodone reported use of four tablets (30 morphine milligram equivalents (MMEs)) or less and used for 1-2 days postoperatively. No patient reported using opioids beyond five days. Only 22.2% reported receiving instruction on opioid disposal, and 16.7% returned unused opioids to a disposal center. 87.1% of subjects rated postoperative pain as “better” or “much better” than expected. Conclusion: Patients undergoing isolated MUS placement require limited amounts of postoperative opioids, if any are needed at all, to achieve satisfactory pain control. Excess prescribed opioids, along with inadequate patient education on proper disposal techniques, may contribute towards opioids that are at risk of diversion for nonmedical use.
- 15 November 2021
- Published by Springer Nature in Cureus
- Vol. 13 (11)
Open AccessOpioid Prescribing and Utilization Following Isolated Mid-Urethral Sling
Introduction: Overprescribing by providers is a leading contributor to the opioid crisis. Despite available information regarding the role that physician prescribing plays in the community availability of opioids, guidelines for the management of acute pain remain sparse. This project aims to evaluate opioid prescribing, opioid usage patterns, and postoperative pain control in patients undergoing isolated mid-urethral sling (MUS) placement. Methods: Patients who underwent isolated MUS placement from March 19, 2019 through March 19, 2020 were contacted by telephone in May 2020 and asked a series of questions examining opioid usage, postoperative pain, what they did with unused opioids, and whether they had received education on disposal techniques. A chart review was utilized to determine the amount of opioid prescribed, the presence of any operative complications, and medical and demographic characteristics of subjects. Results: A total of 53 subjects met inclusion criteria, of which 31 participated in a phone interview. Of the 53 subjects, 54.7% received a postoperative opioid prescription, and all but two of these subjects filled their prescription. Of the interviewed subjects, only 66.6% who filled a prescription reported using opioids Fifty percent (n=6) of patients that required oxycodone reported use of four tablets (30 morphine milligram equivalents (MMEs)) or less and used for 1-2 days postoperatively. No patient reported using opioids beyond five days. Only 22.2% reported receiving instruction on opioid disposal, and 16.7% returned unused opioids to a disposal center. 87.1% of subjects rated postoperative pain as “better” or “much better” than expected. Conclusion: Patients undergoing isolated MUS placement require limited amounts of postoperative opioids, if any are needed at all, to achieve satisfactory pain control. Excess prescribed opioids, along with inadequate patient education on proper disposal techniques, may contribute towards opioids that are at risk of diversion for nonmedical use.
- 27 June 2021
- Published by Springer Nature in Archives of Gynecology and Obstetrics
- Vol. 304 (3) , 713-724
Natural history of urinary incontinence from first childbirth to 30-months postpartum
Purpose The objectives of this study were to determine the incidence of UI in a large cohort of primiparous women before and during pregnancy and over the course of 30-months postpartum, and to identify risk factors for UI during and after pregnancy. Methods Nulliparous women aged 18–35 years with singleton pregnancies were interviewed in their third trimester and asked about urinary incontinence before and during pregnancy (n = 3001). After delivery these women were interviewed at 1, 6, 12, 18, 24 and 30-months postpartum and asked about urinary incontinence occurring in the month prior to each interview. Multivariable logistic regression models identified risk factors for UI during pregnancy and during the follow-up period. Results Overall, 4% reported having urinary incontinence before pregnancy and 36.8% during pregnancy. The strongest predictor of urinary incontinence during pregnancy was urinary incontinence before pregnancy (adjusted OR 13.11, 95% CI 7.43–23.13). Among the women with no subsequent pregnancies, the rate of urinary incontinence increased from 12.5% at 6-months postpartum to 27.4% at 30-months postpartum, 52.1% reported UI at one or more postpartum data collection stages, and the strongest predictors of postpartum UI were UI before pregnancy (adjusted OR 3.95 (95% CI 1.60–9.75) and during pregnancy (adjusted OR 4.36, 95% CI 3.24–5.87). Conclusion Our findings suggest that primiparous women who report UI before and during pregnancy should be monitored for the continuation or worsening of UI over the course of the first 2–3 years postpartum, and treatment options discussed.
- 27 June 2021
- Published by Springer Nature in Archives of Gynecology and Obstetrics
- Vol. 304 (3) , 713-724
Natural history of urinary incontinence from first childbirth to 30-months postpartum
Purpose The objectives of this study were to determine the incidence of UI in a large cohort of primiparous women before and during pregnancy and over the course of 30-months postpartum, and to identify risk factors for UI during and after pregnancy. Methods Nulliparous women aged 18–35 years with singleton pregnancies were interviewed in their third trimester and asked about urinary incontinence before and during pregnancy (n = 3001). After delivery these women were interviewed at 1, 6, 12, 18, 24 and 30-months postpartum and asked about urinary incontinence occurring in the month prior to each interview. Multivariable logistic regression models identified risk factors for UI during pregnancy and during the follow-up period. Results Overall, 4% reported having urinary incontinence before pregnancy and 36.8% during pregnancy. The strongest predictor of urinary incontinence during pregnancy was urinary incontinence before pregnancy (adjusted OR 13.11, 95% CI 7.43–23.13). Among the women with no subsequent pregnancies, the rate of urinary incontinence increased from 12.5% at 6-months postpartum to 27.4% at 30-months postpartum, 52.1% reported UI at one or more postpartum data collection stages, and the strongest predictors of postpartum UI were UI before pregnancy (adjusted OR 3.95 (95% CI 1.60–9.75) and during pregnancy (adjusted OR 4.36, 95% CI 3.24–5.87). Conclusion Our findings suggest that primiparous women who report UI before and during pregnancy should be monitored for the continuation or worsening of UI over the course of the first 2–3 years postpartum, and treatment options discussed.
- Open Access
- 14 May 2021
- Published by Springer Nature in Research Square
Natural History of Urinary Incontinence from First Childbirth to 30 Months Postpartum
Purpose The objectives of this study were to determine the incidence of UI in a large cohort of primiparous women before and during pregnancy and over the course of 30 months postpartum, and to identify risk factors for UI during and after pregnancy. Methods Nulliparous women aged 18 to 35 years with singleton pregnancies were interviewed in their third trimester and asked about urinary incontinence before and during pregnancy (n = 3001). After delivery these women were interviewed at 1, 6, 12, 18, 24 and 30 months postpartum and asked about urinary incontinence occurring in the month prior to each interview. Multivariable logistic regression models identified risk factors for UI during pregnancy and during the follow-up period.Results Overall, 4% reported having urinary incontinence before pregnancy and 36.8% during pregnancy. The strongest predictor of urinary incontinence during pregnancy was urinary incontinence before pregnancy (adjusted OR 13.11, 95% CI 7.43-23.13). Among the women with no subsequent pregnancies, the rate of urinary incontinence increased from 12.5% at 6 months postpartum to 27.4% at 30 months postpartum, 52.1% reported UI at one or more postpartum data collection stages, and the strongest predictors of postpartum UI were UI before pregnancy (adjusted OR 3.95 (95% CI 1.60-9.75) and during pregnancy (adjusted OR 4.36, 95% CI 3.24-5.87). Conclusion Our findings suggest that primiparous women who report UI before and during pregnancy should be monitored for the continuation or worsening of UI over the course of the first 2-3 years postpartum, and treatment options discussed.
- 14 May 2021
- Published by Springer Nature in Research Square
Open AccessNatural History of Urinary Incontinence from First Childbirth to 30 Months Postpartum
Purpose The objectives of this study were to determine the incidence of UI in a large cohort of primiparous women before and during pregnancy and over the course of 30 months postpartum, and to identify risk factors for UI during and after pregnancy. Methods Nulliparous women aged 18 to 35 years with singleton pregnancies were interviewed in their third trimester and asked about urinary incontinence before and during pregnancy (n = 3001). After delivery these women were interviewed at 1, 6, 12, 18, 24 and 30 months postpartum and asked about urinary incontinence occurring in the month prior to each interview. Multivariable logistic regression models identified risk factors for UI during pregnancy and during the follow-up period.Results Overall, 4% reported having urinary incontinence before pregnancy and 36.8% during pregnancy. The strongest predictor of urinary incontinence during pregnancy was urinary incontinence before pregnancy (adjusted OR 13.11, 95% CI 7.43-23.13). Among the women with no subsequent pregnancies, the rate of urinary incontinence increased from 12.5% at 6 months postpartum to 27.4% at 30 months postpartum, 52.1% reported UI at one or more postpartum data collection stages, and the strongest predictors of postpartum UI were UI before pregnancy (adjusted OR 3.95 (95% CI 1.60-9.75) and during pregnancy (adjusted OR 4.36, 95% CI 3.24-5.87). Conclusion Our findings suggest that primiparous women who report UI before and during pregnancy should be monitored for the continuation or worsening of UI over the course of the first 2-3 years postpartum, and treatment options discussed.
- 1 January 2021
- Published by Wolters Kluwer Health in Urogynecology
- Vol. 27 (1) , e191-e195
Urinary Tract Infection After Midurethral Sling
Objective: The aim of the study was to clarify which baseline, operative, and postoperative factors are associated with the development and recurrence of urinary tract infection (UTI) after midurethral sling (MUS). Methods: This is a retrospective analysis of patients who underwent a MUS from February 2010 to April 2014 within a single practice with 2 surgeons. Distribution of perioperative factors with relation to 6-week UTI occurrence (primary outcome) and recurrent UTI (secondary outcome) within a year after surgery were analyzed using Student's t test and χ 2 test. Then, independent risk factors were determined using multiple logistic regression. A P value of less than 0.05 defined statistical significance. Results: From the 500 patients who underwent MUS, 79 (15.8%) developed a UTI within 6 weeks of surgery and 5.8% had recurrent UTI within a year. Looking at the independent effects, patients with a history of recurrent UTI and voiding dysfunction requiring catheterization more than 24 hours were at a higher risk of developing UTI within 6 weeks after surgery. In addition, having a history of recurrent UTI, asymptomatic bacteriuria, and postoperative UTI within 6 weeks after surgery were significantly associated with postoperative recurrent UTI. Conclusions: In this study, we identified baseline and postoperative characteristics that are associated with greater risk of UTI within 6 weeks and recurrent UTI after MUS. These factors can be potentially modified or useful in counseling patients on personalized risks and benefits of the surgical procedure.
- 1 January 2021
- Published by Wolters Kluwer Health in Urogynecology
- Vol. 27 (1) , e191-e195
Urinary Tract Infection After Midurethral Sling
Objective: The aim of the study was to clarify which baseline, operative, and postoperative factors are associated with the development and recurrence of urinary tract infection (UTI) after midurethral sling (MUS). Methods: This is a retrospective analysis of patients who underwent a MUS from February 2010 to April 2014 within a single practice with 2 surgeons. Distribution of perioperative factors with relation to 6-week UTI occurrence (primary outcome) and recurrent UTI (secondary outcome) within a year after surgery were analyzed using Student's t test and χ 2 test. Then, independent risk factors were determined using multiple logistic regression. A P value of less than 0.05 defined statistical significance. Results: From the 500 patients who underwent MUS, 79 (15.8%) developed a UTI within 6 weeks of surgery and 5.8% had recurrent UTI within a year. Looking at the independent effects, patients with a history of recurrent UTI and voiding dysfunction requiring catheterization more than 24 hours were at a higher risk of developing UTI within 6 weeks after surgery. In addition, having a history of recurrent UTI, asymptomatic bacteriuria, and postoperative UTI within 6 weeks after surgery were significantly associated with postoperative recurrent UTI. Conclusions: In this study, we identified baseline and postoperative characteristics that are associated with greater risk of UTI within 6 weeks and recurrent UTI after MUS. These factors can be potentially modified or useful in counseling patients on personalized risks and benefits of the surgical procedure.
- 1 March 2020
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 222 (3) , S787
20: Urinary tract infection following midurethral sling
- 1 March 2020
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 222 (3) , S787
20: Urinary tract infection following midurethral sling
- 1 February 2019
- Published by Elsevier in Journal of Minimally Invasive Gynecology
- Vol. 26 (2) , 198-218
Preemptive Analgesia in Minimally Invasive Gynecologic Surgery
- 1 February 2019
- Published by Elsevier in Journal of Minimally Invasive Gynecology
- Vol. 26 (2) , 198-218
Preemptive Analgesia in Minimally Invasive Gynecologic Surgery
- 1 January 2014
- Published by Society of Urologic Nurses and Associates in Urologic Nursing
- Vol. 34 (3) , 143-51
Female Stress Urinary Incontinence: An Evidence- Based, Case Study Approach
Society of Urologic Nurses and Associates
- 1 January 2014
- Published by Society of Urologic Nurses and Associates in Urologic Nursing
- Vol. 34 (3) , 143-51
Female Stress Urinary Incontinence: An Evidence- Based, Case Study Approach
Society of Urologic Nurses and Associates